Diagnostic Products Corp.: FDA filings under this applicant name
FDA lists 324 510(k) clearances under 2 spellings of the applicant name “Diagnostic Products Corp.” (first 1976, latest 2006), across 118 product codes in 8 review panels. Median 510(k) review time under this name: 50 days. Related companies, subsidiaries and acquired businesses that file under other applicant names are counted on their own pages, not here.
Caduvo groups this applicant name under Siemens Healthineers, based on public ownership records.
510(k) clearances per year
| Year | Clearances | Median review days |
|---|---|---|
| 2012 | 0 | — |
| 2013 | 0 | — |
| 2014 | 0 | — |
| 2015 | 0 | — |
| 2016 | 0 | — |
| 2017 | 0 | — |
| 2018 | 0 | — |
| 2019 | 0 | — |
| 2020 | 0 | — |
| 2021 | 0 | — |
| 2022 | 0 | — |
| 2023 | 0 | — |
| 2024 | 0 | — |
| 2025 | 0 | — |
| 2026 | 0 | — |
Top product codes
| Product code | Device | Submissions | 510(k) clearances |
|---|---|---|---|
| DHB | System, Test, Radioallergosorbent (Rast) Immunological | 26 | 26 |
| CEW | Radioimmunoassay, Parathyroid Hormone | 10 | 10 |
| CDZ | Radioimmunoassay, Testosterones And Dihydrotestosterone | 9 | 9 |
| JJX | Single (Specified) Analyte Controls (Assayed And Unassayed) | 9 | 9 |
| JLW | Radioimmunoassay, Thyroid-Stimulating Hormone | 8 | 8 |
| CDD | Radioassay, Vitamin B12 | 6 | 6 |
| CDP | Radioimmunoassay, Total Triiodothyronine | 6 | 6 |
| CFT | Radioimmunoassay, Prolactin (Lactogen) | 6 | 6 |
| DGC | Ige, Antigen, Antiserum, Control | 6 | 6 |
| DJG | Enzyme Immunoassay, Opiates | 6 | 6 |
Plus 108 more product codes.
Review panels
- Clinical Chemistry (156)
- Clinical Toxicology (69)
- Immunology (66)
- Microbiology (24)
- Hematology (3)
- Pathology (3)
- Dental (1)
- General and Plastic Surgery (1)
Most recent Diagnostic Products Corp. 510(k) clearances
| 510(k) | Device | Product code | Decision date | Review days |
|---|---|---|---|---|
| K063057 | IMMULITE/IMMULITE 1000, IMMULITE 2000 HIGH SENSITIVITY CRP | NQD | 2006-12-22 | 78 |
| K063045 | IMMULITE 2000, IMMULITE 2500 VANCOMYCIN | LEH | 2006-12-05 | 62 |
| K060929 | IMMULITE 2500 VITAMIN B12 MODEL L5KVB2-200 TEST,L5KVB6-600 TEST, IMMULITE 2500 FOLIC ACID MODEL L5KFO2-200 TEST,L5KFO6-6 | CDD | 2006-04-28 | 23 |
| K053533 | IMMULITE/IMMULITE 1000 TURBO INTACT PTH | CEW | 2006-02-03 | 46 |
| K034055 | IMMULITE 2500 CK-MB, 2500 MYOGLOBIN, 2500 STAT TROPONIN I | JHX | 2004-01-21 | 22 |
| K033234 | IMMULITE 2500 AUTOMATED IMMUNOASSAY ANALYZER | DHA | 2003-12-12 | 67 |
| K032881 | IMMULITE/IMMULITE 1000 TOTAL TESTOSTERONE AND IMMULITE 2000 TOTAL TESTOSTERONE | CDZ | 2003-10-10 | 25 |
| K023152 | IMMULITE 2000 ALLERGEN-SPECIFIC IGE | DHB | 2002-12-17 | 85 |
| K023304 | IMMULITE/IMMULITE 1000 CALCITONIN, MODEL LKCL AND IMMULITE 2000 CALCITONIN, MODEL L2KCL | JKR | 2002-12-09 | 67 |
| K022603 | IMMULITE 1000 AUTOMATED IMMUNOASSAY ANALYZER | CEW | 2002-08-21 | 15 |
314 earlier clearances. See the full list in Caduvo.
Recalls
7 product recalls in 7 recall events; 0 initiated in the last five years. Most recent: 2006-01-03.
51 product recalls in 28 recall events filed under other recalling-firm names cite a 510(k) or PMA held under this applicant name; 9 initiated in the last five years. Most often: Siemens Healthcare Diagnostics, Inc. (27), Siemens Healthcare Diagnostics (15), Siemens Healthcare Diagnostics, Inc (4).
These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.
Recalling firms are matched to this applicant name by name only (same normalization), so related entities that recall under another name are not counted. A recall count says nothing about how safe one company's devices are compared with another's.
FDA spellings included
FDA records this applicant under 2 spellings (case, punctuation and legal-suffix variants of one name); this page adds them up. Filings per spelling:
- Diagnostic Products Corp. (321)
- Diagnostic Products Corporation (3)
Other FDA applicant names starting with the same word
FDA records these as separate applicants. Some may belong to the same corporate group and some may not; their filings are not included in the counts above.
- Diagnostic Systems Laboratories, Inc. (94 510(k)s)
- Diagnostic Chemicals, Ltd. (Usa) (77 510(k)s)
- Diagnostic Chemicals , Ltd. (66 510(k)s)
- Diagnostic Reagents, Inc. (66 510(k)s)
- Diagnostic Hybrids, Inc. (36 510(k)s)
- Diagnostic Technology, Inc. (28 510(k)s)
- Diagnostic Solutions, Inc. (26 510(k)s)
- Diagnostic Ultrasound Corp. (16 510(k)s)
- Diagnostic Systems (14 510(k)s)
- Diagnostic Reagent Tech. (10 510(k)s)
- Diagnostic Specialties (8 510(k)s)
- Diagnostic Medical Instruments (5 510(k)s)
Frequently asked questions
How many FDA 510(k) clearances are listed under Diagnostic Products Corp.?
FDA lists 324 510(k) clearances under 2 spellings of the applicant name “Diagnostic Products Corp.” (first 1976, latest 2006), across 118 product codes in 8 review panels. Filings under other applicant names, such as subsidiaries, are not included.
How long has FDA taken to clear 510(k)s filed by Diagnostic Products Corp.?
The median time from FDA receipt to decision across 510(k)s cleared under the name Diagnostic Products Corp. is 50 days.
Which FDA product codes appear under Diagnostic Products Corp.?
The most frequent FDA product codes under this applicant name are DHB (System, Test, Radioallergosorbent (Rast) Immunological, 26); CEW (Radioimmunoassay, Parathyroid Hormone, 10); CDZ (Radioimmunoassay, Testosterones And Dihydrotestosterone, 9).
Next steps
- See all 324 Diagnostic Products Corp. clearances with predicates and recalls
- Run predicate analysis for product code DHB, Diagnostic Products Corp.'s most frequent
Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this data. Data and corrections policy.